Who
John Patrick Moylan
Chief Accounting Officer
Company insider
Files Form 4 as: Chief Accounting Officer, Neogen.
In numbers
- Trades disclosed
- 29
- Buys
- 1
- Sells
- 0
- Bought
- $51K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 May 2024
- Last trade
- 19 Aug 2026
- Last filed
- 20 Aug 2026
Companies traded
Activity over time
1 Apr 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Aug 2026filed 20 Aug 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code F | $28K2,365 at $11.87 | filing |
| 19 Aug 2026filed 20 Aug 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code F | $28K2,365 at $11.87 | filing |
| 14 Aug 2026filed 14 Aug 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code A | $100K8,584 at $11.65 | filing |
| 14 Aug 2026filed 14 Aug 2026 | NEOG Neogenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —18,693 at $0.00 | filing |
| 14 Aug 2026filed 14 Aug 2026 | NEOG Neogenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —18,693 at $0.00 | filing |
| 14 Aug 2026filed 14 Aug 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code A | $100K8,584 at $11.65 | filing |
| 3 Jun 2026filed 4 Jun 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code F | $22K2,553 at $8.75 | filing |
| 3 Jun 2026filed 4 Jun 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code F | $22K2,553 at $8.75 | filing |
| 4 May 2026filed 5 May 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code M | $43K4,558 at $9.53 | filing |
| 4 May 2026filed 5 May 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code F | $15K1,568 at $9.53 | filing |
| 4 May 2026filed 5 May 2026 | NEOG Neogenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | $43K4,558 at $9.53 | filing |
| 4 May 2026filed 5 May 2026 | NEOG Neogenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | $43K4,558 at $9.53 | filing |
| 4 May 2026filed 5 May 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code M | $43K4,558 at $9.53 | filing |
| 4 May 2026filed 5 May 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code F | $15K1,568 at $9.53 | filing |
| 18 Aug 2025filed 20 Aug 2025 | NEOG Neogenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | $11K1,985 at $5.43 | filing |
| 18 Aug 2025filed 20 Aug 2025 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code M | $11K1,985 at $5.43 | filing |
| 18 Aug 2025filed 20 Aug 2025 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code F | $3,220593 at $5.43 | filing |
| 15 Aug 2025filed 19 Aug 2025 | NEOG Neogenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —47,336 at $0.00 | filing |
| 15 Aug 2025filed 19 Aug 2025 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code A | $100K18,416 at $5.43 | filing |
| 2 Jun 2025filed 4 Jun 2025 | NEOG Neogenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —70,574 at $0.00 | filing |
News
Head-To-Head Analysis: Delcath Systems (NASDAQ:DCTH) & Neogen (NASDAQ:NEOG)NEOG · themarketsdaily.com · 18 Oct 2026
0 headlines in the last 90 days name John Patrick Moylan; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.